
Dr. Martens plc
London Stock Exchange-listed British footwear company (DOCS) behind the 1460 boot, reporting GBP 764.9 million in FY2026 revenue.
Company Type
public
Founded
1947
Headquarters
Camden, London, United Kingdom
Stock
London Stock Exchange: DOCS
Revenue
GBP 764.9 million (FY2026)
Employees
Approximately 3,400
Primary Market
Global
Shop Dr. Martens plc Brands
Disclosure: We may earn commission from purchasesAbout Dr. Martens plc
Is Dr. Martens publicly traded?
Yes. Dr. Martens plc trades on the London Stock Exchange under ticker DOCS. It IPO'd in January 2021.
Who owns Dr. Martens?
Public shareholders own the company. Private equity firm Permira, which bought it in 2014, sold down its stake following the IPO.
When was Dr. Martens founded?
The air-cushioned boot was created in 1947 by Klaus Märtens and Herbert Funck in Germany. The iconic 1460 boot launched April 1, 1960, produced by the Griggs family in England.
Where are Dr. Martens made?
Most production is in Vietnam, Laos, and Thailand. The original Wollaston, Northamptonshire factory still produces the small Made in England line.
Who is the CEO of Dr. Martens?
Ije Nwokorie has been CEO since January 2025, leading the consumer-first strategy that delivered a 61 percent adjusted profit increase in fiscal 2026.
How much revenue does Dr. Martens make?
The company reported 764.9 million pounds in fiscal 2026 revenue, down 2.9 percent, with adjusted profit before tax up 61 percent to 55 million pounds.
History of Dr. Martens plc
Klaus Märtens, a Munich-area doctor, created the air-cushioned sole in 1945 after a skiing injury and began production with partner Herbert Funck in 1947 in Seeshaupt, Germany. Bill Griggs acquired the UK license in 1959, and his Northamptonshire factory produced the first 1460 boot on April 1, 1960, in cherry red with yellow stitching.
The boot's journey from workwear to icon was driven by adoption rather than marketing: postmen and police first, then skinheads, punks, and every subsequent subculture made it a countercultural uniform. The Griggs family ran the business for decades through R. Griggs Group.
Near-collapse came in the early 2000s as manufacturing moved offshore. A 2003 restructuring closed most UK production, leaving the Wollaston factory as a symbolic anchor. Permira's 2014 acquisition for roughly 300 million pounds funded the global expansion that rebuilt the company into an international retailer.
The January 2021 IPO valued the company at 3.7 billion pounds, and the public era proved difficult: wholesale overstock, US demand softness, and a channel-led strategy produced repeated profit warnings and a catastrophic share decline. Kenny Wilson departed as CEO in late 2024, and Ije Nwokorie took over in January 2025.
Nwokorie's consumer-first reset pivoted from channel-led to brand-led operations: full-price discipline, reduced clearance, and DTC quality over volume. Fiscal 2026 results showed the strategy working: revenue fell 2.9 percent to 764.9 million pounds as expected while adjusted PBT jumped 61 percent to 55 million pounds, margins improved, and shoes grew 19 percent beyond the boot core.
Dr. Martens plc Sustainability & Ethics
The company's Planet strategy covers materials, manufacturing, and end-of-life, with Leather Working Group supplier standards, vegan product lines, and resale and repair programs in select markets.
The Wollaston factory's continued operation provides a high-standards manufacturing anchor and preserves the Made in England claim on a small product line. No B Corp certification applies.
Labor practices across Asian manufacturing follow industry audit norms, with the company's heritage positioning making supply chain standards a reputational as well as operational issue.
Awards & Recognition
The 1460 boot is a documented design icon, exhibited in museum and design contexts as a twentieth-century classic and among the most copied silhouettes in footwear.
The brand's cultural recognition spans its history: punk retrospectives, fashion exhibitions, and consistent ranking among the world's most valuable footwear brands. Its collaborations with designers and artists produce regularly noted collections that extend the heritage rather than diluting it.
Controversy, Regulation & Public Scrutiny
Post-IPO collapse: The share price decline of more than 80 percent from the 2021 peak, driven by profit warnings and the channel-led strategy's failure, represents the company's dominant recent controversy and the reason for the current strategic reset.
Collaborator dispute: A 2023 public disagreement with a former collaborator over alleged unpaid work was reported in fashion press and resolved without litigation.
Manufacturing shift: The long-ago decision to move most production offshore draws periodic criticism given the brand's British identity, partially answered by the retained Made in England line at Wollaston.
Brands Owned by Dr. Martens plc
Dr. Martens plc owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Dr. Martens plc
public · Founded 1947 · Camden, London, United Kingdom
1
brands
Stock Information
Dr. Martens plc Ownership: Pros & Cons
Advantages
- +Single iconic product with six decades of cultural equity
- +Public listing provides capital access and transparency
- +Made in England line preserves authentic heritage
- +Turnaround delivering profit growth with margin improvement
- +Global recognition surviving every fashion cycle
Considerations
- -Post-IPO performance destroyed most shareholder value
- -Single-brand concentration offers no diversification
- -Wholesale dependence created the overstock problem
- -Counterfeit exposure from the iconic design
- -Asia manufacturing concentration carries tariff risk
Frequently Asked Questions About Dr. Martens plc
Is Dr. Martens publicly traded?
Yes. Dr. Martens plc trades on the London Stock Exchange under ticker DOCS. It IPO'd in January 2021.
Who owns Dr. Martens?
Public shareholders own the company. Private equity firm Permira, which bought it in 2014, sold down its stake following the IPO.
When was Dr. Martens founded?
The air-cushioned boot was created in 1947 by Klaus Märtens and Herbert Funck in Germany. The iconic 1460 boot launched April 1, 1960, produced by the Griggs family in England.
Where are Dr. Martens made?
Most production is in Vietnam, Laos, and Thailand. The original Wollaston, Northamptonshire factory still produces the small Made in England line.
Who is the CEO of Dr. Martens?
Ije Nwokorie has been CEO since January 2025, leading the consumer-first strategy that delivered a 61 percent adjusted profit increase in fiscal 2026.
How much revenue does Dr. Martens make?
The company reported 764.9 million pounds in fiscal 2026 revenue, down 2.9 percent, with adjusted profit before tax up 61 percent to 55 million pounds.





